Last reviewed · How we verify
Low dose vaccine
At a glance
| Generic name | Low dose vaccine |
|---|---|
| Sponsor | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Injection site pain
- Injection site erythema
- Injection site swelling
- Headache
- Pyrexia
- Nausea
- Influenza
- Injection site pruritus
- Dizziness
- Administration site pain
- Nasopharyngitis
- Fatigue
Key clinical trials
- Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) (PHASE1)
- Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults (PHASE1)
- Combination Study of SV-BR-1-GM With Retifanlimab (PHASE1, PHASE2)
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) (PHASE1)
- Iron and Immune Response to Vaccine (IRONMUM) (NA)
- The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) (PHASE1)
- A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza (PHASE1)
- Trial of an Inactivated Chikungunya Virus Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |